This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Reprints and Permissions Copyright Information Books from ASM Press MicrobeWorld Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Grasela, T H Articles by Kinkel, A W Search for Related Content PubMed PubMed Citation Articles by Grasela, T H, Jr Articles by Kinkel, A W

 Previous Article  |  Next Article 

Antimicrob Agents Chemother. 1989 May; 33(5): 615-617

Inhibition of enoxacin absorption by antacids or ranitidine.

T H Grasela Jr, J J Schentag, A J Sedman, J H Wilton, D J Thomas, R W Schultz, M E Lebsack and A W Kinkel

School of Pharmacy, State University of New York, New York.

ABSTRACT

Ten normal volunteers participated in a randomized, five-way crossover study to determine the effect of concurrent enoxacin and antacid or ranitidine administration on enoxacin absorption. The bioavailability of a single oral 400-mg enoxacin dose was significantly decreased, by 73 and 49%, when Maalox TC was administered 0.5 and 2 h before enoxacin, respectively. Enoxacin bioavailability was not significantly altered when the antacid was given 8 h before or 2 h after enoxacin administration. Ranitidine, administered intravenously 2 h before enoxacin, also significantly decreased enoxacin bioavailability, by 40%. The correlation between the proximity of antacid administration and the magnitude of the decrease in enoxacin bioavailability supports complexation as the mechanism of the antacid-enoxacin interaction. However, reduction of enoxacin bioavailability by ranitidine suggests that elevated gastric pH may also play a role in the antacid-enoxacin drug-drug interaction.

---

Antimicrob Agents Chemother. 1989 May; 33(5): 615-617

This article has been cited by other articles:

• Nassr, N., Lahu, G., Hunnemeyer, A., von Richter, O., Knoerzer, D., Reutter, F., Zech, K., Hermann, R. (2007). Magnesium Hydroxide/Aluminium Hydroxide-Containing Antacid Does Not Affect the Pharmacokinetics of the Targeted Phosphodiesterase 4 Inhibitor Roflumilast. J Clin Pharmacol 47: 660-666 [Full Text]  
• Grunder, G., Zysset-Aschmann, Y., Vollenweider, F., Maier, T., Krahenbuhl, S., Drewe, J. (2006). Lack of Pharmacokinetic Interaction between Linezolid and Antacid in Healthy Volunteers. Antimicrob. Agents Chemother. 50: 68-72 [Abstract] [Full Text]